NasdaqGM - Nasdaq Real Time Price USD
Protara Therapeutics, Inc. (TARA)
3.9400
+0.0900
+(2.34%)
At close: April 22 at 4:00:00 PM EDT
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
181,454
78,954
113,290
172,596
Total Liabilities Net Minority Interest
14,320
10,633
11,207
10,682
Total Equity Gross Minority Interest
167,134
68,321
102,083
161,914
Total Capitalization
167,134
68,321
102,083
161,914
Common Stock Equity
167,134
68,321
102,083
161,914
Capital Lease Obligations
4,483
5,467
6,384
7,239
Net Tangible Assets
163,889
65,660
101,999
132,397
Working Capital
161,194
62,556
80,406
88,814
Invested Capital
167,134
68,321
102,083
161,914
Tangible Book Value
163,889
65,660
101,999
132,397
Total Debt
4,483
5,467
6,384
7,239
Share Issued
35,044.7720
11,364.9030
11,267.3890
11,235.7310
Ordinary Shares Number
35,044.7720
11,364.9030
11,267.3890
11,235.7310
12/31/2021 - 10/22/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
LRMR Larimar Therapeutics, Inc.
2.3800
+18.41%
IMUX Immunic, Inc.
1.0000
+1.10%
CGON CG Oncology, Inc.
20.48
+0.34%
BCAX Bicara Therapeutics Inc.
13.82
+9.25%
INZY Inozyme Pharma, Inc.
1.0300
+5.17%
TECX Tectonic Therapeutic, Inc.
19.49
+8.76%
XENE Xenon Pharmaceuticals Inc.
36.73
+5.85%
URGN UroGen Pharma Ltd.
10.05
+4.04%
STOK Stoke Therapeutics, Inc.
9.22
+7.08%
EWTX Edgewise Therapeutics, Inc.
13.53
+1.73%